Innova Captab Ltd.

₹696.5

-4.5 (-0.6%)

INNOVACAP Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,940 Cr

P/E Ratio31.08

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	675.78	Bullish
10-DMA	671.78	Bullish
20-DMA	696.75	Bearish
50-DMA	709.01	Bearish
100-DMA	770.56	Bearish
200-DMA	830	Bearish

Historical Performance

1 Year

-22.2%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	12,437	10,813	9,264	8,005	4,107
Total Expenditure	10,575	9,269	8,127	7,045	3,562
Other Income	120	125	92	29	14
Operating Profit	1,982	1,669	1,228	989	559
Interest	24	215	200	57	39
Depreciation	248	160	111	75	56
Profit Before Tax	1,710	1,295	918	857	463
Consolidated Net Profit	1,283	943	680	638	344
Adjusted EPS	22	16	14	13	7

Compounded Sales Growth

10 Years:28.4

5 Years:27.2

3 Years:9.2

TTM:2.8

Compounded Profit Growth

10 Years:45.1

5 Years:35.7

3 Years:15

TTM:6.3

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:-26.9

Return on Equity

10 Years:N/A

5 Years:7.2

3 Years:14.2

last year:22.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	572	572	480	120	120
Total Reserves	9,022	7,737	2,285	1,966	1,328
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,557	2,045	1,942	881	445
Other Current Liabilities	773	580	205	283	690
Short Term Borrowings	656	238	979	1,201	334
Total Liabilities	15,916	13,294	7,482	6,122	4,045
Capital Work in Progress	225	3,408	215	---	73
Long Term Loans & Advances	68	220	1,011	288	476
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	781	801	276	501	261
Total Current Assets	7,191	6,082	4,425	4,000	2,705
Total Assets	15,916	13,294	7,482	6,122	4,045
Adjusted Book Value	168	145	58	43	30

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 31.08, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 13.4%, reflecting average market performance.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹1982 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹12437 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 731195.2

No. of Shares: 1050 (Approx)

Performance:-26.9%

P/L: ₹-268804.8

NIFTY Performance: 9.4%

1 day Top Gainers